Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$15.23 - $21.72 $178,526 - $254,601
-11,722 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$17.8 - $23.5 $18,832 - $24,863
1,058 Added 9.92%
11,722 $253,000
Q1 2021

May 17, 2021

BUY
$17.18 - $22.6 $183,207 - $241,006
10,664 New
10,664 $216,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.